Treatment(s) now being considered-Radical mastectomy Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Radical mastectomy Posts on Medivizor

Evaluating the effectiveness of three exercise programs and intensive follow-up in improving quality of life, pain, and lymphedema among breast cancer survivors

Evaluating the effectiveness of three exercise programs and intensive follow-up in improving quality of life, pain, and lymphedema among breast cancer survivors

Posted by on Feb 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of three exercise programs in improving quality of life (QOL), pain, and lymphedema among breast cancer (BC) survivors. The study found that joint mobility exercise (JME) combined with progressive resistance exercise (PRE) showed promising results in improving QOL and lymphedema after BC...

Read More

Does exercise increase recovery in patients undergoing surgery for breast cancer?

Does exercise increase recovery in patients undergoing surgery for breast cancer?

Posted by on Jul 21, 2021 in Breast cancer | 0 comments

In a nutshell This study was carried out to examine the impact of physical activity (PA) on the recovery of patients having surgery for breast cancer (BC). The authors found that PA reduces the risk of patients developing chronic pain and women who had higher levels of PA recovered better than sedentary women.  Some background BC is one of...

Read More

Is nab-paclitaxel a better option than standard solvent-based taxanes for women with breast cancer?

Is nab-paclitaxel a better option than standard solvent-based taxanes for women with breast cancer?

Posted by on Feb 28, 2021 in Breast cancer | 0 comments

In a nutshell This study explored whether nanoparticle albumin-bound (nab) paclitaxel (Abraxane) is more efficient as chemotherapy before surgery compared to solvent-based (sb) taxanes in patients with breast cancer. The authors found that nab-paclitaxel was able to improve the outcomes of these patients. Some background Breast cancer...

Read More

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Posted by on Feb 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the role of circulating tumor cells (CTCs) in deciding adjuvant therapy (AT; treatment after surgery) in patients with breast cancer (BC). This study showed that personalized AT based on CTCs improved patient survival. Some background BC that has not spread to other areas of the body is called non-metastatic...

Read More

Evaluating radiation therapy after breast removal surgery for node-positive triple-negative breast cancer.

Evaluating radiation therapy after breast removal surgery for node-positive triple-negative breast cancer.

Posted by on Dec 28, 2020 in Breast cancer | 0 comments

In a nutshell This study was carried out to assess the use of radiotherapy (RT) after mastectomy (surgical removal of the breast) for triple-negative breast cancer (TNBC) that has spread to the lymph nodes. The authors found that RT after surgery was associated with improved survival in patients with larger tumors. Some background Triple-negative...

Read More

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Posted by on Nov 5, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness of breast-conserving surgery (BCS) to mastectomy (breast-removal surgery) after chemotherapy in patients with breast cancer. The authors found that BCS does not result in a lower survival in these patients. Some background BC is one of the most common forms of cancer in women. Standard care...

Read More

Does the addition of human endostatin to chemotherapy before surgery benefit patients with stage III breast cancer?

Does the addition of human endostatin to chemotherapy before surgery benefit patients with stage III breast cancer?

Posted by on Sep 29, 2020 in Breast cancer | 0 comments

In a nutshell This trial was carried out to examine the use of recombinant human (rh) endostatin (EN) with CT before surgery in patients with breast cancer (BC). The authors concluded that the addition of EN to CT significantly improved the response rate to therapy and survival in these patients. Some background BC is the most common form of...

Read More

Does it matter how much healthy tissue is removed during surgery for patients with breast cancer who received chemotherapy first?

Does it matter how much healthy tissue is removed during surgery for patients with breast cancer who received chemotherapy first?

Posted by on Apr 18, 2020 in Breast cancer | 0 comments

In a nutshell This study examined if there was a difference in patients with breast cancer first treated with chemotherapy that had a wide or narrow margin of healthy tissue removed during surgery. The results showed that the outcomes were similar regardless of how much healthy tissue was removed. Some background Traditionally, mastectomy (the...

Read More

Adding targeted therapy to chemotherapy and surgery in patients with breast cancer

Adding targeted therapy to chemotherapy and surgery in patients with breast cancer

Posted by on Dec 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding targeted therapies to chemotherapy before surgery improved outcomes in patients with breast cancer. The study found that patients responded to treatment better when a targeted therapy was added to chemotherapy and surgery treatment. Some background There are multiple ways to treat breast...

Read More